Interaction between inflammation and blood viscosity predicts cardiovascular mortality

Scandinavian Cardiovascular Journal

Volumn 44, Issue 2, 2010, Pages 107-112

  Skretteberg, Per Torger ^a   Bodegård, Johan ^a   Kjeldsen, Sverre E ^a   Erikssen, Gunnar ^b   Thaulow, Erik ^b   Sandvik, Leif ^c   Erikssen, Jan E ^d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Cardiovascular disease; Epidemiology; Erythrocyte sedimentation rate; Hematocrit

Indexed keywords

CHOLESTEROL;

ADULT; AGE; ARTICLE; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FITNESS; FOLLOW UP; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD SEDIMENTATION; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; INFLAMMATION; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NORWAY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 77949575543     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017430903171248     Document Type: Article

References (25)

1. Danesh J, Collins R, Peto R, 1. Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease. Eur Heart J. 2000; 21: 515-520.
2. Andresdottir MB, S igfusson N, S igvaldason H, G udnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study. Am J Epidemiol. 2003; 158: 844-851.
3. Erikssen G, Liestol K, Bjornholt JV, Stormorken H, Thaulow E, Erikssen J. Erythrocyte sedimentation rate: A possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. Eur Heart J. 2000; 21: 1614-1620.
4. Erikssen G, Thaulow E, Sandvik L, Stormorken H, E rikssen J. Haematocrit: A predictor of cardiovascular mortality?. J Intern Med. 1993; 234: 493-499.
5. de Simone G, Devereux RB, C hien S, A lderman MH, A tlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 1990; 81: 107-117
6. Erikssen J, E nge I, Forfang K, Storstein O. F alse positive diagnostic tests and coronary angiographic fi ndings in 105 presumably healthy males. Circulation. 1976; 54: 371-376
7. Erikssen J, S krede S. S erum lipids and latent coronary insuffi ciency. Scand J Clin Lab Invest. 1977; 37: 243-250.
8. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Infl ammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351: 2599-2610.
9. Ridker PM, D anielson E, F onseca FA, Genest J, G otto AM, Jr Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359: 2195-2207.
10. Koenig W, S und M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of infl ammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999; 99: 237-242.
11. Mendall MA, Strachan DP, Butland BK, B allam L, M orris J, Sweetnam PM, et al. C-reactive protein: Relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000; 21: 1584-1590.
12. Ridker PM, C ushman M, S tampfer MJ, T racy RP, H ennekens CH. Infl ammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336: 973-979.
13. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of fi rst myocardial infarction. Circulation. 1998; 97: 2007-2011.
14. Somer T, M eiselman HJ. Disorders of blood viscosity. A nn Med. 1993; 25: 31-39.
15. Lowe G, R umley A, Norrie J, F ord I, Shepherd J, C obbe S, et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost. 2000; 84: 553 - 8.
16. Fuchs J, Weinberger I, Rotenberg 16. Z, E rdberg A, D avidson E, Joshua H, et al. Plasma viscosity in ischemic heart disease. Am Heart J. 1984; 108: 435-439.
17. Thomas DJ, M arshall J, R ussell RW, W etherley-Mein G, du Boulay GH, Pearson TC, et al. Effect of haematocrit on cerebral blood-fl ow in man. Lancet. 1977; 2: 941-943.
18. Wells R. Microcirculation and coronary blood fl ow. A m J Cardiol. 1972; 29: 847-850.
19. Duke WW. T he relation of blood platelets to hemorrhagic disease. By W.W. Duke. JAMA. 1983; 250: 1201-1209.
20. Bottiger LE, C arlson LA. H emoglobin, plasma lipids, and coronary heart disease. Am Heart J. 1973; 86: 842-844.
21. Baumgartner HR, Turitto V, Weiss HJ. E ffect of shear rate on platelet interaction with subendothelium in citrated and native blood. II. Relationships among platelet adhesion, thrombus dimensions, and fi brin formation. J Lab Clin Med. 1980; 95: 208-221.
22. Turitto VT, W eiss HJ. R ed blood cells: Their dual role in thrombus formation. Science. 1980; 207: 541-543.
23. Turitto VT, W eiss HJ, B aumgartner HR. T he effect of shear rate on platelet interaction with subendothelium exposed to citrated human blood. Microvasc Res. 1980; 19: 352-365.
24. Nakanishi N, Suzuki K, T atara K. H aematocrit and risk of development of Type 2 diabetes mellitus in middle-aged Japanese men. Diabet Med. 2004; 21: 476-482.
25. Strand A, G udmundsdottir H, H øieggen A, Fossum E, Bjørnerheim R, Os I, et al. Increased hematocrit before blood pressure in men who develop hypertension over 20 years. J Am Soc Hypertension. 2007; 1: 400-406.